Cannabis startup CannPal to list on ASX, targets $4.7m IPO

Happy dog in a marijuana field.

CannPal Animal Therapeutics, a Sydney-based pharmaceutical technology startup, is looking to raise A$6 million ($4.74 million) in its initial public offer (IPO) on the Australian Securities Exchange (ASX) slated for October 2017.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.